Announcements Trials
Browse Landscape

Status

Completed 3Terminated 1

Sponsor Class

OTHER 2INDUSTRY 2

Study Type

Interventional 32Observational 4

Sponsor

Cancer Type

Genitourinary 4

Conditions

Prostatic Neoplasms 3Castrate Refractory Metastatic Prostate Cancer (mCRPC) 1

Interventions

Surveys and Questionnaires 52Blood Specimen Collection 47enzalutamide 29radium Ra 223 dichloride 22Biopsy 20darolutamide 19Radiotherapy 19Docetaxel 19apalutamide 18Sunitinib 18Magnetic Resonance Spectroscopy 18Sorafenib 17Abiraterone Acetate 17Watchful Waiting 16Interviews as Topic 15Gene Expression Profiling 15Amplified Fragment Length Polymorphism Analysis 15Observation 13Leuprolide 13Immunohistochemistry 13Androgen Antagonists 13acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 12Magnetic Resonance Imaging 12avelumab 11Specimen Handling 11abiraterone 9Polymerase Chain Reaction 9Flow Cytometry 9Radiosurgery 8Microarray Analysis 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Observational × sipuleucel-T × Genitourinary × Clear all
NCT02353715 2020-12-24

PEAX

Duke University

Completed
38 enrolled
Genitourinary

Prostatic Neoplasms

NCT01727154 2019-08-19

PRIME

Dendreon

Terminated
139 enrolled 11 charts
Genitourinary

Prostatic Neoplasms

NCT01306890 2019-06-07

PROCEED

Dendreon

Completed
1,976 enrolled 20 charts
Genitourinary

Prostatic Neoplasms

NCT02232230 2019-01-09

A Multicenter Trial Enrolling Men With Advanced Prostate Cancer Who Are to Receive Combination Radiation and Sipuleucel-T

GenesisCare USA

Completed
20 enrolled
Genitourinary

Castrate Refractory Metastatic Prostate Cancer (mCRPC)

Data powered by HemOnc (CC BY 4.0) Colophon âš¡